Enjoy complimentary customisation on priority with our Enterprise License!
The global enteral feeding devices market size is estimated to grow/decline by USD 1.54 billion, at a CAGR of 6.78% between 2023 and 2028. There has been a significant increase in new product launches in the market. This increase in new product launches across product lines provides better options to buyers which fuels the overall product demand for medical equipment in the market. Due to this growth, several healthcare equipment manufacturers are seeking opportunities to convert this rise in demand into a continuous cycle of innovation and improvisation for improved products. One of the main product launches in the market is the launch of ENFit nasogastric tubes by FirmlyMedical for enteral nutrition in the UK. Hence, such factors are positively impacting the market. It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
ALCOR Scientific: The company offers SENTINELplus Enteral Feeding Pump with dual display and simple alarms.
Amsino International Inc., Applied Medical Technology Inc., Avanos Medical Inc., B.Braun SE, Becton Dickinson and Co., Boston Scientific Corp., Canafusion Technologies Inc., Cardinal Health Inc., Conmed Corp., Cook Group Inc., Danone SA, Fresenius SE and Co. KGaA, HMC Premedical Spa, Medela AG, Medline Industries LP, Moog Inc., Shenzhen Bestman Instrument Co. Ltd., Trendlines Group Ltd., and Vygon SAS
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The hospital segment is estimated to witness significant growth during the forecast period. One of the main end-users of the market are the hospitals which serve as a significant setting for the use of devices. There is an increasing need for nutritional support for patients in ICUs, surgical wards, and other specialized units due to their medical conditions and the need for close monitoring. In addition, it is used extensively for patients who are unable to ingest food orally due to circumstances including trauma or surgery to get essential nutrients and drugs.
Get a glance at the market contribution of various segments Download PDF Sample
The hospital segment was the largest segment and was valued at USD 1.76 billion in 2018. Factors such as the growing incidence of chronic illnesses including cancer, neurological disorders, and gastrointestinal diseases have resulted in more patients requiring nutritional support during hospitalization. The rise in the global aging population has resulted in higher rates of age-related conditions and illnesses that need hospitalization. Additionally, due to the compromised nutritional intake of elderly patients, devices have become essential to maintain their health during hospital stays. Furthermore, the advancement in technologies has improved patient comfort, accuracy, and ease of administration. Hence, such factors are expected to fuel the growth of the segment which in turn will drive the growth of the market during the forecast period.
For more insights about the market share of various regions Download PDF Sample
North America is estimated to contribute 49% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. Some of the main factors that are significantly contributing to the growth of the market in North America include the rising prevalence of chronic conditions such as cancer and neurological disorders, the increasing number of product launches with technological advances, the increasing presence of regional and global market players, and initiatives by government and non-profit organizations to create awareness.
Additionally, the growing cases of chronic conditions such as neurological disorders and cancer are positively impacting the growth of the market in the region. For example, in 2023, 11,580 new cases of laryngeal cancers and 54,540 new cases of oral cavity cancers and pharynx cancers were recorded in the US. Hence, such factors are expected to drive the market in the region during the forecast period.
The market is propelled by the rising geriatric population and the prevalence of chronic illnesses like diabetes, severe pancreatitis, and gastrointestinal diseases. Patients in surgical trauma ICUs benefit from specialized devices like tri-funnel replacement G-tubes and J-tubes. Research from NCBI highlights the importance of enteral feeding in managing conditions such as Parkinson’s, Alzheimer’s, osteoporosis, and osteoarthritis. Enteral feeding pumps and tubes play a crucial role in delivering parenteral and enteral nutrition to patients, reducing complications. Additionally, advancements in enteral feeding devices cater to pediatric and neonatal patients, addressing neonatal mortality and morbidity associated with preterm births and genetic disorders. There are multiple factors influencing market growth. Our researchers analyzed the market research and growth data with 2023 as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage.
One of the key factors driving the market growth is the increasing prevalence of chronic conditions and preterm birth. There is a growing prevalence of chronic conditions, such as cancers neurological conditions, and preterm births across the globe which is fuelling the adoption of devices. In addition, there is an increasing prevalence of oral cancer which develops on the tongue, oral mucosa, mouth, and oropharynx (area of the throat at the back of the mouth).
Moreover, smoking and frequent consumption of alcohol are some of the major factors attributed to the growth of oral cancer. For instance, in the US, in 2023, approximately 54,540 new total cases of oral cavity and oropharyngeal cancers and 11,580 deaths from oral cavity or oropharyngeal cancers. Hence, such factors are expected to drive market growth and trends during the forecast period.
A key factor shaping the market is the growing advancements in devices. Enteral feeding devices comprise smart pump technology with features such as dose accuracy, flow rate control, and alarm systems. The main advantage of these pumps is that they can also wirelessly connect to healthcare provider systems for real-time monitoring and data exchange, thereby ensuring precise delivery and minimizing the risk of errors.
Moreover, one of the main advancements includes devices with built-in technologies to verify proper tube placement thereby helping in preventing misplacements and reducing the risk of complications like aspiration. Hence, such factors are expected to positively impact the market. Therefore, it is expected to drive the market growth during the forecast period.
Frequent product recalls are one of the key challenges hindering the market growth. There has been a significant increase in frequent product recalls in the medical equipment industry due to safety or functionality issues. Therefore, the medical equipment needs to be checked, adjusted, or fixed to ensure that it does not fail unexpectedly or violate regulatory guidelines.
Moreover, recalls are done by medical equipment manufacturers to inspect and repair them so that they do not cause serious health issues in patients. For instance, in May 2022, the US FDA recalled the Cortrak*2 enteral access system for the risk of misplaced enteral tubes manufactured by Avanos Medical. Hence, such factors are negatively impacting the market which in turn will hinder the market growth during the forecast period.
The market forecast report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market forecasting and growth strategies.
Customer Landscape
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
You may also interested in below market reports:
The market is pivotal for neonatal care, addressing neonatal mortality, morbidity, and genetic disorders, including rare genetic diseases like Prader-Willi Syndrome. Enteral feeding pumps and tubes are crucial for neonates and infants, contributing to revenue growth despite initial placement complications. These devices mitigate mechanical, clinical, and nutritional problems, reducing healthcare costs for third-party payers. Developing nations, particularly in Latin America, Asia Pacific, and the Middle East, benefit from reimbursement policies and federal funding, emphasizing home healthcare services. Additionally, enteral feeding devices, including enterostomy tubes placed in the abdominal wall, stomach, duodenum, and jejunum, see advancements through endoscopy, laparoscopy, and open surgery, providing long-term support.
Moreover, technological innovations like reverse balloon designs and tri-funnel replacement enterostomy tubes cater to chronic diseases such as multiple sclerosis, liver disease, motor neuron disease, Parkinson's disease, sepsis, anorexia, cystic fibrosis, dementia, and inflammatory bowel disease. Integrating these devices into healthcare systems, whether in acute hospitals or community settings, supports diverse patient needs, including diabetes and balanced nutritional intake. Tube feeds are essential in cancer-preventive treatment regimens, enabling enteral feeding devices to be seamlessly used at home. Further, the market is witnessing steady growth driven by various factors such as the rising geriatric population and an increase in the prevalence of conditions like severe pancreatitis and nervous system disorders.
Consequently, such devices, including tri-funnel replacement G-tubes and J-tubes, play a crucial role in providing nutrition to patients in surgical trauma ICUs and those suffering from chronic diseases like Alzheimer’s disease, osteoporosis, and osteoarthritis. They are also vital for pediatric patients, neonatal patients, and pre-term infants who require parenteral nutrition or enteral feeding tubes. With advancements in bolus delivery and human milk administration, these devices facilitate effective feeding and management of conditions like congenital genetic disorders. Research, such as NCBI studies, continues to underscore the importance of enteral feeding devices in managing chronic diseases and supporting patients requiring parenteral feeding therapies. These devices play a critical role in addressing challenges such as the incidence of preterm births and facilitating essential functions like swallowing, suckling, and breathing in vulnerable populations.
Market Scope |
|
Report Coverage |
Details |
Page number |
163 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.78% |
Market growth 2024-2028 |
USD 1537 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
6.23 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 49% |
Key countries |
US, UK, Canada, China, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
ALCOR Scientific, Amsino International Inc., Applied Medical Technology Inc., Avanos Medical Inc., B.Braun SE, Becton Dickinson and Co., Boston Scientific Corp., Canafusion Technologies Inc., Cardinal Health Inc., Conmed Corp., Cook Group Inc., Danone SA, Fresenius SE and Co. KGaA, HMC Premedical Spa, Medela AG, Medline Industries LP, Moog Inc., Shenzhen Bestman Instrument Co. Ltd., Trendlines Group Ltd., and Vygon SAS |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.